What we're reading, March 9, 2016: prescription drugs accounted for 16.7% of US healthcare spending in 2015; the FDA will allow Amarin to promote a prescription fish oil for off-label uses; and racial disparities for infant mortality persist.
Prescription drugs accounted for 16.7% of all US healthcare spending in 2015, according to a report from HHS. STAT reported that rising drug prices and more expensive medicines coming to market drove the increase in prescription drug spending, which had only been 7% of healthcare spending back in the 1990s. Through 2018, drug spending is expected to outpace the growth in overall healthcare spending.
The FDA has reached a settlement with Amarin to allow its prescription fish-oil drug to be promoted for unapproved uses. The FDA said that the settlement was specific to this particular case and would not mark a new legal precedent, according to the Associated Press. However, the settlement opens up the opportunity for companies to pursue more aggressive legal action against the FDA.
Racial disparities in infant mortality persist despite a 13% drop in the national infant mortality rate. USA Today reported that black infants are dying at a rate that is more than twice the rate of white babies and black mothers are twice as likely to have expensive premature births. Extending nurse home visits to all eligible mothers would cost $60 billion over 10 years but would save $21 billion after that.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More